2 tracked superinvestors hold Caris Life Sciences Inc (CAI), worth $209M combined, led by Philippe Laffont. Smart money is holding CAI as of the latest 13F filings.
Current price
$25.07
-31.0%
1Y
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms.…
Market cap
$5.2B
P/E
-5.74
Div yield
0.0%
Revenue YoY
97.0%
Analyst target
—
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$209M
disclosed long exposure
Tier-1 conviction
2
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding CAI steady this quarter — buys and sells are balanced.
Caris Life Sciences Inc (CAI) is held by 2 tracked funds worth $209M combined, 2 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Philippe Laffont at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.4% | $175M | |
| Held | 0.6% | $34M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
3 insiders filed SEC Form 144 for $18M of proposed sales in the last 90 days. A 144 is filed before the trade — see who else is selling.
| Insider | Role | Shares | Value | Filed |
|---|---|---|---|---|
| David Spetzler | Officer | 119,212 | $3M | 2026-09-04 |
| David Spetzler | Officer | 478,000 | $12M | 2026-09-03 |
| George H Poste Revocable Trust | Former Affiliate | 100,000 | $3M | 2026-08-24 |
| George H Poste | Director | 30,000 | $643K | 2026-08-07 |
Which superinvestors own CAI?
2 tracked funds hold Caris Life Sciences Inc (CAI), the largest being Philippe Laffont (Coatue Management) at 0.4% of its 13F portfolio. 2 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling CAI?
In the most recent 13F quarter, 0 tracked funds added or opened CAI and 0 trimmed it.
How much CAI do tracked funds hold?
Combined disclosed long exposure to CAI across tracked superinvestors is $209M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.